Resources for Patients and their Families
Request Free Guide

Mesothelioma Doctors

Linda L. Garland, M.D.

Dr. Garland
Tucson, AZ

Dr. Linda L. Garland

Director, Clinical Lung Cancer Program

University of Arizona Cancer Center

North Campus
3838 N. Campbell Ave.
Tucson, AZ 85719
(520) 626-3434

Need Help Contacting This Doctor?

University of Texas Health Science Center - 1988

University of South Florida College of Medicine

H. Lee Moffitt Cancer Center


As a medical oncologist, Dr. Linda Lee Garland coordinates and oversees medical care for patients with cancer. She specializes in experimental therapeutics in the treatment of chest cancers, including lung cancer and mesothelioma. Dr. Garland is the director of the Clinical Lung Cancer Program at the University of Arizona Cancer Center located in Tucson, Arizona and is a full investigator in the Cancer Prevention and Control Program. She also teaches at the University of Arizona College of Medicine, where she is an associate professor of clinical medicine.

Educational Background

Dr. Garland attended medical school at the University of Texas Health Science Center in San Antonio, Texas, then went on to complete a residency in internal medicine at the University of South Florida College of Medicine. She specialized in hematology and oncology during a fellowship at the H. Lee Moffitt Cancer Center in Tampa, Florida.

Clinical and Laboratory Research

Dr. Garland has built her career around searching for promising new ways to fight for cancer. Experimental therapeutics is the main focus of her research, particularly related to malignant diseases of the chest. Chemotherapy has limited effectiveness when dealing with lung cancers, especially because the disease tends to be diagnosed at a late stage. Therefore, doctors like Dr. Garland are interested in exploring other treatments, including new chemotherapy drugs that may be more effective at fighting tumors while causing fewer side effects.

At the University of Arizona Cancer Center, Dr. Garland was part of a team that performed the region’s first successful extrapleural pneumonectomy, a surgery aimed at battling malignant mesothelioma.

Additional Work

Dr. Garland is board certified by the American Board of Internal Medicine in the area of Medical Oncology.

Relevant Publications

Garland L., Flores F., Tsao A. “Individualizing mesothelioma treatment: Small Steps into a Brighter Future”, Clinical Lung Cancer, Vol. 11, No. 6, 371-373. 

Garland L, Rankin C, Gandara D, Rivkin S, Scott K, Nagle R, Altomare D, Klein-Szanto A, Testa R, Borden E. “A Phase II study of oral EGFR tyrosine kinase inhibitor erlotinib in patients with malignant pleural mesothelioma: A Southwest Oncology Group Study.” J Clin Oncol 2007:25; 2406-2413.

Garland L, Taylor C, Pilkington D, Cohen J, Von Hoff D. “A Phase I Pharmacokinetic Study of HMN-214, a Novel Oral Stilbene Derivative With Polo-Like Kinase-1 Interacting Properties, in Patients With Advanced Solid Tumors.” Clin Cancer Res 2006:12; 5182-9.

Author: Linda Molinari

Editor in Chief, Mesothelioma Cancer Alliance

Linda Molinari

Reviewer: Annette Charlevois

Patient Support Coordinator

Annette Charlevois


Linda Garland, M.D.

“Surgeons Extending Lives in Battle Against Mesothelioma”

“Individualizing Mesothelioma Treatment: Small Steps Into a Brighter Future”

Mesothelioma Treatment Guide

Free Mesothelioma Treatment Guide

Please fill in the form below to request our FREE Mesothelioma Treatment Guide. It will be sent to you within 24 hours.

Have you or someone you know been diagnosed with mesothelioma?

Get Access To:

Legal Rights Information Guide Free Guide Request Free Guide Free Mesothelioma Guide Free 2019 Mesothelioma Guide